News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
159,640 Results
Type
Article (6384)
Company Profile (59)
Press Release (153196)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (53215)
Career Advice (178)
Deals (9329)
Drug Delivery (10)
Drug Development (20801)
Employer Resources (22)
FDA (3481)
Job Trends (3549)
News (84202)
Policy (6451)
Tag
Academia (517)
Accelerated approval (5)
Allergies (41)
Alliances (6895)
ALS (41)
Alzheimer's disease (461)
Antibody-drug conjugate (ADC) (72)
Approvals (3646)
Artificial intelligence (79)
Autoimmune disease (33)
Automation (6)
Bankruptcy (54)
Best Places to Work (3198)
Biosimilars (50)
Biotechnology (42)
Bladder cancer (50)
Brain cancer (15)
Breast cancer (200)
Cancer (1337)
Cardiovascular disease (111)
Career advice (155)
Career pathing (3)
CAR-T (50)
CDC (5)
Cell therapy (135)
Cervical cancer (13)
Clinical research (18139)
Collaboration (228)
Compensation (148)
Complete response letters (10)
COVID-19 (1037)
CRISPR (11)
C-suite (67)
Cystic fibrosis (44)
Data (1992)
Depression (22)
Diabetes (164)
Diagnostics (1657)
Digital health (6)
Diversity, equity & inclusion (3)
Drug discovery (47)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (36)
Earnings (40351)
Editorial (7)
Employer branding (3)
Employer resources (22)
Events (26131)
Executive appointments (70)
FDA (4432)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (8)
Funding (200)
Gene editing (19)
Generative AI (5)
Gene therapy (91)
GLP-1 (237)
Government (1112)
Grass and pollen (2)
Guidances (310)
Healthcare (5259)
HIV (12)
Huntington's disease (9)
IgA nephropathy (21)
Immunology and inflammation (61)
Immuno-oncology (10)
Indications (37)
Infectious disease (1099)
Inflammatory bowel disease (79)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (26)
Interviews (24)
IPO (6102)
IRA (4)
Job creations (538)
Job search strategy (133)
JPM (8)
Kidney cancer (4)
Labor market (28)
Layoffs (88)
Leadership (2)
Legal (1002)
Liver cancer (23)
Longevity (4)
Lung cancer (201)
Lymphoma (134)
Machine learning (5)
Management (7)
Manufacturing (100)
MASH (38)
Medical device (3702)
Medtech (3714)
Mergers & acquisitions (3467)
Metabolic disorders (345)
Multiple sclerosis (62)
NASH (1)
Neurodegenerative disease (65)
Neuropsychiatric disorders (16)
Neuroscience (738)
NextGen: Class of 2026 (1140)
Non-profit (1013)
Now hiring (8)
Obesity (139)
Opinion (17)
Ovarian cancer (34)
Pain (28)
Pancreatic cancer (47)
Parkinson's disease (45)
Partnered (6)
Patents (69)
Patient recruitment (84)
Peanut (21)
People (7946)
Pharmaceutical (9)
Pharmacy benefit managers (6)
Phase 1 (4705)
Phase 2 (7805)
Phase 3 (7407)
Pipeline (2188)
Policy (24)
Postmarket research (682)
Preclinical (1687)
Press Release (10)
Prostate cancer (57)
Psychedelics (6)
Radiopharmaceuticals (60)
Rare diseases (182)
Real estate (745)
Recruiting (12)
Regulatory (5356)
Reports (17)
Research institute (526)
Resumes & cover letters (27)
Rett syndrome (8)
RNA editing (2)
RSV (24)
Schizophrenia (44)
Series A (24)
Series B (22)
Service/supplier (2)
Sickle cell disease (21)
Special edition (9)
Spinal muscular atrophy (52)
Sponsored (6)
Startups (512)
Stomach cancer (2)
Supply chain (13)
Tariffs (36)
The Weekly (2)
Vaccines (309)
Venture capital (17)
Weight loss (90)
Women's health (15)
Worklife (3)
Date
Today (25)
Last 7 days (120)
Last 30 days (462)
Last 365 days (8032)
2026 (583)
2025 (8221)
2024 (9220)
2023 (10572)
2022 (11861)
2021 (32761)
2020 (12062)
2019 (9429)
2018 (6995)
2017 (6722)
2016 (5373)
2015 (7182)
2014 (4889)
2013 (3426)
2012 (3755)
2011 (4212)
2010 (3658)
Location
Africa (102)
Alabama (12)
Alaska (1)
Arizona (34)
Arkansas (1)
Asia (9644)
Australia (1323)
California (2771)
Canada (912)
China (249)
Colorado (137)
Connecticut (149)
Delaware (117)
Europe (21792)
Florida (372)
Georgia (90)
Hawaii (1)
Idaho (8)
Illinois (207)
India (13)
Indiana (191)
Iowa (1)
Japan (133)
Kansas (73)
Kentucky (9)
Louisiana (11)
Maine (23)
Maryland (273)
Massachusetts (2058)
Michigan (63)
Minnesota (193)
Mississippi (1)
Missouri (27)
Montana (8)
Nebraska (1)
Nevada (27)
New Hampshire (22)
New Jersey (1025)
New Mexico (5)
New York (839)
North Carolina (339)
Northern California (1378)
Ohio (59)
Oregon (3)
Pennsylvania (599)
Puerto Rico (6)
Rhode Island (3)
South America (201)
South Carolina (3)
Southern California (1137)
Tennessee (33)
Texas (395)
United States (10273)
Utah (82)
Virginia (41)
Washington D.C. (9)
Washington State (252)
Wisconsin (22)
159,640 Results for "23".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards - January 23, 2026
January 26, 2026
·
1 min read
Press Releases
GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
February 4, 2026
·
1 min read
Press Releases
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
February 3, 2026
·
1 min read
Press Releases
Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23
January 27, 2026
·
4 min read
Press Releases
RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy
February 4, 2026
·
4 min read
Press Releases
Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)
January 23, 2026
·
7 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 23, 2026
January 26, 2026
·
1 min read
Press Releases
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 23, 2026
January 26, 2026
·
2 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 23, 2026
January 26, 2026
·
2 min read
Mergers & acquisitions
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.
June 16, 2025
·
2 min read
·
Tristan Manalac
1 of 15,964
Next
